The Danish Version of the Surgical Fear Questionnaire

Status Not yet recruiting

Clinical Trial Summary

The aim of this translation and validation study is to make the The Dutch Surgical Fear Questionnaire (SFQ) applicable in adult Danish speaking patients referred to surgery. After succesful translation of the SFQ, 200 adult patients referred to surgery at Gødstrup Hospital will be invited to answer the SFQ as well as two other questionnaires for the validation: The Pain Catastrophizing Scale (PCS) and The Hospital Anxiety and Depression Scale (HADS). Statistical analysis will be performed to assess the correlation between the scales and thus the validity of the SFQ.

Clinical Trial Description

Some of the instruments for assessing surgical fear are the Amsterdam Preoperative Anxiety and Information Scale (APAIS), the Hospital anxiety and depression scale (HADS), the State-Trait Anxiety Inventory (STAI) and the Visual Analog Scale assessing Anxiety (VAS-A). However, HADS, STAI and VAS-A ask questions not particular related to perioperative procedures and thus seem too generic and APAIS seems unspecific despite questions directly related to anaesthesia and the surgical procedure. The Dutch Surgical Fear Questionnaire (SFQ) was developed to be suitable for general use among all types of adult surgery patients to assess self-reported surgical fear, and to cover a broad range of short-term and long-term surgery-related fears. The translation and validation follows the standardized multistep process outlined by Cha, Kim, and Erlen: 1) forward translation, 2) backward translation by native speakers, 3) a test of the translation in a pilot population of adults referred to surgery at Gødstrup Hospital, and 4) validation in a clinical population. For the validation of quantitatively measured clinical variables (clinimetric validation), convergent validity will be assessed between SFQ, the Pain Catastrophizing Scale (PCS) and the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A). The Cronbach's alpha test will be employed to assess the internal consistency of the SFQ subscales and the overall score. Approval of the study has been obtained from the Institutional Review Board at Central Denmark Region. Informed consent will be obtained from all participants prior to inclusion. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06392698
Study type	Observational
Source	Gødstrup Hospital
Contact	Brigitta R Villumsen, Postdoc
Phone	+45 20487820
Email	brigvill@rm.dk
Status	Not yet recruiting
Phase
Start date	June 10, 2024
Completion date	June 20, 2025

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02377609` - To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks	N/A
Completed	`NCT05236101` - Validation of Child Drawing Hospital Scale (CD: H) and the Place of the Drawing in the Evaluation of Dental Anxiety	N/A
Completed	`NCT02845128` - Prospective Validation of the ROX Index
Completed	`NCT04778007` - The Validation of the Turkish Version of the LUMP Questionnaire
Recruiting	`NCT05871411` - Validation of Visual Analog Scales to Measure SatisfactiOn and WELL-being at Work (SoWell-VAS)
Completed	`NCT03162835` - Development and Clinimetric Properties of the Dutch Pediatric Neurophysiology of Pain Questionnaire in Healthy Children
Recruiting	`NCT05970835` - Validation of a Mobile App as an Adjuvant Treatment	N/A
Completed	`NCT04465903` - Validity and Reliability of the Turkish Version of the Sydney Swallow Questionnaire
Completed	`NCT04477174` - Validity and Reliability of the Turkish Translation of the Yale Pharyngeal Residue Severity Rating Scale
Completed	`NCT02625285` - Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative	N/A
Not yet recruiting	`NCT04208672` - Validation of a Handy Sleep Monitoring Device: UMindSleep in Patients With Obstructive Sleep Apnea	N/A
Completed	`NCT00340756` - Evaluating Serum Sex Steroid Hormones	N/A
Completed	`NCT05678920` - Validation of the Turkish Version of the Modified Early Obstetric Warning Systems (MEOWS) Charts

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.